Fidelity Investments’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119M | Buy |
10,442,467
+110,256
| +1% | +$1.26M | 0.01% | 1045 |
|
|
2025
Q1 | $123M | Sell |
10,332,211
-302,020
| -3% | -$3.59M | 0.01% | 1005 |
|
|
2024
Q4 | $200M | Buy |
10,634,231
+10,047,329
| +1,712% | +$189M | 0.01% | 824 |
|
|
2024
Q3 | $13.2M | Buy |
586,902
+511,256
| +676% | +$11.5M | ﹤0.01% | 1839 |
|
|
2024
Q2 | $1.58M | Buy |
75,646
+4,284
| +6% | +$89.4K | ﹤0.01% | 2403 |
|
|
2024
Q1 | $1.05M | Sell |
71,362
-252,367
| -78% | -$3.71M | ﹤0.01% | 2486 |
|
|
2023
Q4 | $3.34M | Buy |
323,729
+2,822
| +0.9% | +$29.1K | ﹤0.01% | 2180 |
|
|
2023
Q3 | $2.52M | Sell |
320,907
-95,706
| -23% | -$752K | ﹤0.01% | 2225 |
|
|
2023
Q2 | $4.16M | Sell |
416,613
-33,631
| -7% | -$336K | ﹤0.01% | 2117 |
|
|
2023
Q1 | $4M | Sell |
450,244
-553,399
| -55% | -$4.91M | ﹤0.01% | 2158 |
|
|
2022
Q4 | $11M | Sell |
1,003,643
-682,008
| -40% | -$7.49M | ﹤0.01% | 1846 |
|
|
2022
Q3 | $22M | Sell |
1,685,651
-105,004
| -6% | -$1.37M | ﹤0.01% | 1580 |
|
|
2022
Q2 | $22.7M | Buy |
1,790,655
+668,632
| +60% | +$8.47M | ﹤0.01% | 1601 |
|
|
2022
Q1 | $15.7M | Buy |
1,122,023
+13,920
| +1% | +$195K | ﹤0.01% | 1902 |
|
|
2021
Q4 | $32.1M | Buy |
1,108,103
+449,486
| +68% | +$13M | ﹤0.01% | 1600 |
|
|
2021
Q3 | $19.7M | Hold |
658,617
| – | – | ﹤0.01% | 1855 |
|
|
2021
Q2 | $17.5M | Buy |
658,617
+79,532
| +14% | +$2.11M | ﹤0.01% | 1895 |
|
|
2021
Q1 | $18M | Buy |
579,085
+243,400
| +73% | +$7.57M | ﹤0.01% | 1840 |
|
|
2020
Q4 | $11M | Hold |
335,685
| – | – | ﹤0.01% | 1937 |
|
|
2020
Q3 | $11.7M | Buy |
+335,685
| New | +$11.7M | ﹤0.01% | 1773 |
|